Dicerna Pharmaceuticals, Inc.’s collaboration agreement with Alexion Pharmaceuticals, Inc.

Foley Hoag LLP advised Dicerna Pharmaceuticals, Inc. on the transaction Dicerna entered into a collaboration with Alexion Pharmaceuticals, Inc. to discover and develop RNA interference therapies...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here